Fulgent Genetics, Inc.·4

Mar 2, 8:01 PM ET

Kim Paul 4

Research Summary

AI-generated summary

Updated

Fulgent Genetics (FLGT) CFO Kim Paul Sells Shares to Cover Taxes

What Happened Kim Paul, CFO and Treasurer of Fulgent Genetics (FLGT), had a total of 10,648 shares withheld to satisfy tax-withholding obligations tied to vesting restricted stock units (RSUs). The withholding transactions were recorded as dispositions (code F) and totaled approximately $174,249:

  • 1,168 shares at $24.76 on 2026-02-26 for $28,920
  • 1,133 shares at $15.33 on 2026-03-01 for $17,369
  • 8,347 shares at $15.33 on 2026-03-01 for $127,960

These were not open-market sales driven by a choice to liquidate but shares withheld (cashless) to cover taxes on vested RSUs.

Key Details

  • Transaction dates and prices: 02/26/2026 @ $24.76; 03/01/2026 @ $15.33 (two separate withholdings).
  • Total shares withheld: 10,648; total proceeds: ~$174,249.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: F1, F2, F3 indicate the shares were withheld to satisfy tax withholding on RSUs granted on Feb 26, 2024; Feb 28, 2022; and Feb 25, 2025 (each grant previously reported on Form 4).
  • Filing timeliness: Form 4 filed on 2026-03-02; timing appears consistent with standard Form 4 reporting deadlines.

Context

  • Code F transactions denote tax-withholding on vested equity (a routine administrative action), so these withholdings generally do not signal an insider’s change in view about the company.
  • For retail investors, purchases by insiders tend to be more informative than routine withholdings; treat this filing as administrative rather than a directional trade.